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1. Introduction  
The blood-brain barrier (BBB) is a dynamic interface between the blood and the central 
nervous system (CNS), that controls the exchanges between the blood and brain 
compartments. Therefore, the functional and structural integrity of the BBB is vital to 
maintain the homeostasis of the brain microenvironment and it provides protection against 
many toxic compounds and pathogens (Cardosa et al., 2010; Cucullo et al., 2011).  
Anatomically, the BBB consists of microvascular endothelial cells (ECs) lining the brain 
microvessels together with the perivascular elements such as astrocytes, pericytes, neurons, 
and the extracellular matrix. The microcapillary endothelium is characterized by the 
presence of tight junctions (TJs), lack of fenestrations, and minimal pinocytotic vesicles. TJs 
between the cerebral ECs form a diffusion barrier, which selectively excludes most blood-
borne substances from entering the brain, protecting it from systemic influences. Brain ECs 
also express plasma membrane transport protein and receptors, both of which provide 
selective routes of entry for polar nutrients such as glucose transport (GLUT-1), ions (Na, K-
ATPase and Na, K) and some macromolecules (insulin and transferring receptors) and 
routes of exit for potentially toxic metabolic waste and macromolecules (ATP-binding 
cassette (ABC) transporters). Through restrictive barrier properties and polarized expression 
of selective transport proteins, the BBB effectively regulates solute and fluid exchange 
between the blood and brain parenchyma (Marchi et al., 2011a; Paolinelli et al., 2011). 
The BBB is a dynamic system, capable of responding to local changes and requirements, and 
is regulated by a number of mechanisms and cell types, in both physiological and 
pathological conditions. Such regulation includes changes in tight junction function, and in 
expression and activity of many transporters and enzymes (Abbott et al., 2010). BBB 
breakdown has often been documented in the epileptic brains (Ilbay et al., 2003; Uzüm et al., 
2006). Recently, as within many CNS diseases, also in epilepsy, BBB dysfunction have been 
described not only as a late event, but more interestingly as putatively involved in the early 
steps of disease progression. It is well acknowledged that epileptic seizures are the result of 
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instant abnormal hypersynchronous electrical activity of neuronal network, originating 
from discharges of local brain tissue that caused by an imbalance between excitation and 
inhibition. However, in a substantial number of epilepsies, the etiology is almost unknown. 
The complex and multifactorial nature of epileptogenesis (occurrence of spontaneous 
epileptic seizures) has highlighted the fact that limited therapeutic solutions in clinical 
practice are left to a proportion of epilepsy patients that are refractory to all anti-epileptic 
drugs (AEDs). During the past several years, increasing interest has arisen in the role of the 
BBB in epilepsy. Recent advances in understanding nature of epileptogenesis have made it 
possible to realize the role of the BBB disruption in epileptogenesis (David et al., 2009; de 
Boer et al., 2008; Vezzani et al., 2008; Weis et al., 2009; You et al., 2011). 
2. Blood- Brain Barrier: Structure and function 
The BBB is localized at the interface between the blood and the cerebral tissue and, formed 
by the ECs of cerebral blood vessels which are characterized by the absence of fenestration 
correlating with the presence of intercellular TJs, the low level of non specific transcytosis 
and paracellular diffusion of hydrophilic compounds. ECs have a high number of 
mitochondria, associated with a strong metabolic activity and the polarized expression of 
membrane receptors and transporters, which are responsible for the active transport of 
blood-borne nutrients to the brain or the efflux of potentially toxic compounds from the 
neural tissues to the vascular compartment (Weis et al., 2009). 
BBB properties are primarily determined by junctional complexes between the cerebral ECs. 
These complexes are comprised of TJs and adherens junctions (AJs). Such restrictive 
angioarchitecture at the BBB reduces paracellular diffusion, while minimal vesicle transport 
activity in brain ECs limits transcellular transport. Under normal conditions, this largely 
prevents the extravasation of macromolecules and most polar solutes (unless specific 
transporters are present) and prevents migration of any type of blood-borne cell. In AJs, 
cadherin proteins span the intercellular cleft and are linked into the cell cytoplasm by the 
scaffolding proteins alpha, beta and gamma catenin. The AJs hold the cells together giving 
the tissue structural support. They are essential for formation of TJs, and disruption of AJs 
leads to barrier disruption. The TJs consist of a complex of proteins spanning the 
intercellular cleft (occludin, nectin, claudins), and junctional adhesion molecules A, B and C 
(JAMs). TJs adhesion proteins are linked to a specific network of cytoskeletal and signaling 
proteins which include ZOs (zonula occludens proteins 1, 2, 3 and zonula occludens-1 
associated nucleic-acid-binding protein (ZONAB), cingulin and others). The TJs are 
responsible for the severe restriction of the paracellular diffusional pathway between the 
ECs to ions and other polar solutes, and effectively block penetration of macromolecules by 
this route. The impediment to ion movement results in the high in vivo electrical resistance 
of the BBB, of  1800 Ω cm2. This high electrical resistance or low conductance of the 
potential paracellular pathway emphasises the extreme effectiveness of the TJs in occluding 
this pathway by effectively reducing the movement of ions (Abbott et al., 2010; Paolinelli et 
al., 2011; Stamatovic et al., 2008). However, the BBB is a dynamic structure capable of rapid 
modulation in response to physiological or pathological signals. The permeability can be 
controlled by a variety of signaling pathways that regulate TJs organization. Numerous 
substances and signaling tracks, such as Ca2+, protein kinase C, G protein, calmodulin, 
cAMP, phospholipase C, and tyrosine kinases, are believed to play a role in this regulation. 
Several cytoplasmic signaling molecules are concentrated at TJs complexes and are involved 
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in signaling cascades that control assembly and disassembly of TJs. ZOs proteins link 
claudins and occludin via cingulin to intracellular actin cytoskeleton. Importantly, it has 
been shown that ZO-1 and ZONAB are a substrate of a serine kinase and protein kinase C, 
respectively, which are crucial for the formation and regulation of TJs. Failure to maintain 
the integrity of brain EC junctions can have profound effects on permeability control. 
(Paolinelli et al., 2011). In addition, the BBB is structurally associated with brain 
parenchymal cells. Pericytes, glial cells (especially astrocytes), neurons, together with the 
basal lamina (also called lamina basalis) ensheathing cerebral blood vessels, are indirectly 
involved in the establishment and maintenance of the BBB (Figure 1). These various cell 
types and basal lamina collectively constitute the neurovascular unit (NVU), a concept 
recently proposed to highlight the functional interactions that control the BBB integrity. The 
basal lamina of the cerebral endothelium is constituted by 3 apposed layers, one produced 
by ECs and containing laminin -4 and -5, one being astrocyte-derived, containing laminin -1 
and -2 and the collagen IV-containing the middle one, contributed by both cell types. All 
three layers are also made of various types of collagen, glycoproteins and proteoglycans. 
The basal lamina of the cerebral endothelium shows strong labeling with cationic colloidal 
gold indicating that it forms a negatively charged screen or filter controlling the movement 
of charged solutes between blood and the brain interstitial fluid. Therefore large, charged 
molecules such as ferritin do not cross the basal lamina. Multiple basal lamina proteins, 
matrix metalloproteases and their inhibitors are involved in the dynamic regulation of the 
BBB in physiological as well as pathological conditions. (Cardosa et al., 2010; Marchi et al., 
2011a; Nag, 2003a; Weis et al., 2009).  
 
Fig. 1. Schematic representation of the BBB structure. 
Induction and maintenance of many BBB properties depends on a close association with 
astrocytes. Astrocytes are one of the important components of NVU. Astrocytes are glial 
cells whose end feet form a lacework of fine lamellae closely apposed to the outer surface of 
the BBB endothelium and respective basement membrane (Figure 2). They play a major role 
in promoting proteoglycan synthesis with a resultant increase in brain microvascular ECs 
charge selectivity. On the other hand, a number of astrocyte-released and more generally 
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glial-released factors have been suggested to contribute to BBB integrity, including glial-
derived neurotrophic factor, angiopoietin-1 and more recently angiotensin II. Another 
important cell that contributes to the NVU is the pericytes. Pericytes are cells that are 
present along brain and non-brain microvessels, within the basal lamina surrounding 
ECs; interestingly, brain microvessels are notably rich in pericytes and the pericytes/ECs 
ratio has been correlated with the barrier capacity of the endothelium. Pericytes are 
actively involved in maintenance of the integrity of the vessel, vasoregulation and 
restricted BBB permeability. ECs, astrocytes and pericytes are in close contact with 
neuronal projections, allowing neuronal mediators to affect cerebral blood flow and vessel 
dynamics. However, the precise physiological or pathophysiological consequences of 
neuronal input onto the BBB remain largely unknown (Cardosa et al., 2010; Marchi et al., 
2011a; Weis et al., 2009). 
 
Fig. 2. Note that astrocytes's endfeet are in contact with the endothelial surface. 
As mentioned above, BBB properties are primarily determined by junctional complexes 
between the cerebral ECs and NVU. However, it is necessary to put those junctions into 
the context of other BBB properties. These include the general paucity of vesicular 
transport at the BBB, the presence of enzymes that by degradation prevent the entry of a 
variety of compunds, and the presence of a wide range of transport systems. Because non-
lipid soluble compounds only diffuse slowly across the BBB, the latter are necessary for 
both the entrance of nutrients into brain and the clearance of waste products from brain 
(Stamatovic et al., 2008). 
In general, the brain ECs has a very low number of vesicles under normal conditions 
compared to other types of ECs. However, during some disease states the number of 
vesicles can increase. Fusion between vesicles may eventually lead to the formation of 
transendothelial channels and/or vesicle/vacuolar organelles (VVO). Transendothelial 
channels correspond to chains of two or more fused vesicles that are open simultaneously 
on the luminal and abluminal side of ECs. Besides that, channels made by one of the vesicle 
open on the both sides of ECs can occur. VVO on the other hand are large collection of 
interconnected vesicles and vacuoles. The fusion of vesicles, vacuole with luminal and 
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abluminal plasma membranes creates transcellular pathways confirmed in the several 
ultrastructural studies (Stamatovic et al., 2008).   
The BBB can also act as an enzymatic barrier, capable of metabolizing drug and nutrients. 
The ECs particularly in the BBB contain elevated concentrations of enzymes that are 
involved in metabolizing neuroactive blood-borne solutes. Such enzymes are Ǆ-glutamyl 
transpeptidase, alkaline phosphatase, aromatic acid decarboxylase, and monoamine 
oxidases. These enzymes are often polarized between the luminal and abluminal membrane 
surface of brain ECs. We know that, the barrier to paracellular diffusion potentially isolates 
the brain from many essential polar nutrients such as glucose and amino acids. However, 
the BBB endothelium must contain a number of specific solute transporters to supply the 
CNS with these substances. The brain ECs forming the BBB expresses transport proteins for 
a wide variety of solutes and nutrients, mediating flux into and out of the brain. For 
example, the BBB has very high levels of the glucose transporter 1, GLUT1, and the large 
neutral amino acid transporter, LAT1, that facilitate movement of those nutrients from 
blood to brain. Other transporters are involved in ion homeostasis and the transport of 
signaling molecules between blood and brain. Ions or small molecules are mostly 
transferred through the brain ECs by transporters/carriers/channels present on the plasma 
membrane. Most macromolecules move across brain capillary endothelium by bulk phase 
non-receptor mediated endocytosis. For example, cationic macromolecules prefer uptake by 
clathrin coated membranes and pits and are subsequently delivered to and degraded in 
lysosomes. There are also efflux transporters that move compounds from brain to blood. 
Efflux transporters of the ATP Binding Cassette (ABC) family transport a large panel of 
lipophilic molecules, in particular xenobiotics, against a concentration gradient by ATP 
hydrolysis. The most active ABC-transporters at the BBB are P-glycoprotein (P-gp) encoded 
by the multidrug resistance gene (MDR1 or ABCB1), multidrug resistance proteins (MRPs, 
or ABCC proteins) and the breast cancer resistance protein (BCRP or ABCG2). The major 
role of the ABC transporters in the BBB is to function as active efflux pumps consuming 
ATP and transporting a diverse range of lipid-soluble compounds out of the brain capillary 
endothelium and the CNS. In this role, they are removing from the brain potentially 
neurotoxic endogenous or xenobiotic molecules and they are carrying out a vital 
neuroprotective and detoxifying function. In addition, many drugs are substrates for these 
ABC efflux transporters and their brain penetration is significantly reduced (Abbott et al., 
2010; Stamatovic et al., 2008; Weiss et al., 2009). 
3. Blood- Brain Barrier dysfunction in epilepsy: Experimental and clinical 
studies 
The BBB breakdown has been recognized long ago in experimental and human epilepsy. 
There have been numerous reports indicating that seizures may produce an increase in 
cerebral capillary permeability (Ruth et al., 1984; Ilbay et al., 2003; Sheen et al., 2011). On the 
other hand, epileptogenic process may also be triggered by impaired function of BBB (Oby 
and Janigro, 2006).  Generally, the duration of seizure activity is correlated with reduced 
BBB functions. However, with increased arterial blood pressure, the BBB becomes 
permeable to macromolecules under induced epileptiform seizures (Öztas et al., 1991; Sheen 
et al., 2011). Studies reveal that an acute increase in blood pressure or epileptic activity 
causes an increase in pinocytosis at the level of the cerebral endothelium (Ilbay et al., 2003; 
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Oby and Janigro, 2006). There is also information from earlier experiments indicating that 
this BBB alteration is reversible and confined to anatomically limited brain areas. BBB 
openings have been mapped for a variety of convulsive agents with different mechanisms of 
action (i.e., impairment of GABA transmission, increased glutamate neurotransmission, 
direct excitatory action) (Oby and Janigro, 2006; Vezzani et al., 2008). A direct link between 
the mechanism of action and the region where BBB breakdown was observed is not obvious. 
However, a few brain regions are easily affected by seizure activity irrespective of the means 
of induction. Other regions of the brain show BBB breakdown only under the influence of 
specific convulsants. It is shown that seizures induced by pentylenetetrazole primarily affect 
thalamus, hypothalamus, midbrain and cerebellum (Sahin et., 2003; Uzüm et al., 2006) 
(Figure 3). Also, the GABA-receptor blocker bicuculline induces loss of barrier in 
hippocampus whereas kainic acid induces alterations in capillaries of the neocortical brain 
areas (Nitsch et al., 1983). The results of our previous study demonstrated that generalised 
tonic-clonic convulsions, together with elevated blood pressure resulted in BBB opening in 
multiple areas (Ilbay et al., 2003; Sahin et al., 2003), (Figures 4).  Unfortunately, while several 
models are available to study the BBB in animal models, a suitable (i.e., microscopic, 
quantitative, and minimally invasive) technique for evaluating BBB integrity in humans 
does not exist. However, studies on human epileptic tissue show clear BBB abnormalities, 
including increased micropinocytosis and fewer mitochondria in ECs, a thickening of the 
basal membrane, and the presence of abnormal Tjs. Finally, it can be stated that opening of 
BBB is present before, during or after epileptic seizures, is a hallmark of vascular injury in 
the brain and there are multiple factors involved in etiology of BBB breakdown in epilepsy 
(Oby and Janigro., 2006; Stamatovic et al., 2008; Vezzani et al., 2008;). 
It has been demonstrated that, seizures and epilepsy often develop after traumatic, ischemic, 
or infectious brain injury. After injury, local compromise of BBB integrity is common 
(Abbott et al., 2010; Cacheaux et al 2009; Oby and Janigro, 2006), as revealed by 
ultrastructural studies of animal and human epileptic tissue in multiple forms of epilepsy. 
(Cacheaux et al 2009; Marchi et al., 2007a; van Vliet et al., 2007), and BBB opening may 
specifically serve as a trigger event leading to epilepsy. However, the research field has 
recently considered the fact that damage to the cerebral vasculature could be involved in the 
pathogenesis of seizures (Oby & Janigro, 2006).  
While large amount of published data support a correlation between occurrence of 
spontaneous epileptic seizures, seizures and abnormal BBB, direct evidence for the 
involvement of BBB breakdown in epileptogenesis has been only recently confirmed by the 
studies, in which opening of the BBB was sufficient to induce delayed epileptiform activity 
(Cacheaux et al., 2009; Seiffert et al., 2004). 
Epileptogenesis in the BBB-disrupted brain seems to be mediated by exposure of the brain 
cortex to serum albumin, mediated via its action on brain astrocytes. The possible 
involvement of albumin in astrocytic activation and proliferation is supported by previous 
studies. Based on the studies, it was concluded that there is a specific glial receptor (TGF-ǃ) 
and signaling pathway for the action of albumin.  Thus, it seems plausible that damage to 
the microvasculature during brain insults leads to the extravasation of serum proteins, 
leading to the transformation of the neighboring astrocytes as the primary step in the 
epileptogenic process. In addition, it is notable that in many cases of epilepsy, as well as in 
most animal models, neuronal damage is observed. In this respect it is interesting to point 
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out that BBB breakdown has been associated with early or delayed neuronal damage to 
what extent this damage contributes to epileptogenesis, a result of abnormal activity or not 
related, is not as yet clear (David et al., 2009; Friedman et al., 2011;  vanVliet et al., 2007).  
 
Fig. 3. Patern of BBB opening after PTZ-induced seizures is demonstrated. Regional 
distribution indicated as percent of total number of animal exhibiting EB leakage. BBB 
opening is most pronounced and frequently observed in the deep brain areas (Sahin et al., 
2003). 
 
Fig. 4. Pattern of BBB opening after hot water-induced epilepsy is demonstrated. Regional 
distribution indicated as percent of total number of animal exhibiting EB leakage. BBB 
opening is most pronounced in cortical areas (Ilbay et al., 2003). 
Experimental evidence also supports a role of intravascular inflammation, often associated 
with BBB damage, in seizure disorders (Marchi et al., 2007a; Marchi et al., 2009; Seiffert et 
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al., 2004; van Vliet et al., 2007). Recently, the association between circulating immune cells, 
their interaction with the BBB, and seizure propensity was proposed; leukocyte adhesion 
was shown to directly support ictogenesis in the pilocarpine model of seizures (Fabene et 
al., 2008). A recent study conducted on patients affected by temporal lobe epilepsy 
demonstrated an increase in circulating natural killer cells and cytotoxic T lymphocytes 
(Bauer et al., 2008). The results were limited by blood analysis at one single time point, 
making the relationship of these findings to seizures uncertain. These results are, however, 
comparable to what was reported in the pilocarpine model of epilepsy (Marchi et al., 2007b), 
where an increase in circulating CD8+ cytotoxic T lymphocytes was measured. In general, 
concordant data have been obtained using either models of peripheral inflammation, 
regardless of the initiating trigger; activation of white blood cells was observed prior to 
development of seizures. Moreover, when kainic acid was used to induce seizures, a 
contribution of the immune response was demonstrated, suggesting the influence of the 
adaptive immune response on kainic acid induced hippocampal neurodegeneration (Chen 
et al., 2004; Silverberg et al., 2010). Taken together, these findings support a link between 
seizures and immunity in both animal models and in a clinical scenario. The molecular 
players linking white blood cells activation to BBB damage and seizures are, however, still 
unknown (Marchi et al., 2011b; Marchi et al., 2009).  
BBB dysfunction is a major etiological event of seizure disorder in GLUT-1 deficiency 
syndrome. Glucose is the principal energy source for the brain and a continuous supply of 
this substrate is essential to maintain normal cerebral function. GLUT-1 ensures nutrient 
delivery, supplying glucose for the brain, which is its main energy source. GLUT-1 is highly 
restricted to the capillary ECs in the brain. The GLUT-1 deficiency syndrome is attributed to 
a defect of GLUT1 causing impaired transport of glucose across the BBB, interfering with 
cerebral energy metabolism and brain function, ultimately leading to seizures. GLUT1 
deficiency syndrome has led to the investigation of the properties of GLUT1 in epilepsy. 
Many clinical studies showed that by using fluoro-2-deoxy-D-glucose positron emission 
tomography (FDG-PET) of patients with complex partial seizures yielded interictal scans 
that exhibit hypometabolic regions including the epileptic focus as identified by 
electroencephalography (EEG). In contrast, ictal scans showed focal, multifocal and 
generalized increases in the metabolic rate. However, ictal hypermetabolism did not always 
correspond to regions of interictal hypometabolism. Recent studies concluded that in 
epileptogenic temporal cortex both the physiology of blood flow and glucose metabolism 
are altered (Oby & Janigro, 2006). It is hypothesized that the interictal zone of 
hypometabolism coincides with altered BBB transporter activity and demonstrated that the 
zone of reduced metabolism according to a FDG-PET corresponds to a region of decreased 
BBB glucose transporter activity (Cardoso et al., 2010; Cornford et., 1999; Oby & Janigro, 
2006). Moreover, human and animal epilepsy studies suggest that, a ketogenik diet leads to 
anticonvulsant consequences (Masino et al., 2011). The findings of these studies underline 
that BBB-related hypometabolism may be a common feature of focal epilepsy and not only 
limited to molecular changes in GLUT1 transporter expression.  
Another important aspect of BBB function is its control of drug transport to brain. 
Permeability of the BBB determines the bioavailability of therapeutic drugs and resistance to 
chemically different AEDs. ABC efflux transporters at the BBB influence the brain uptake of 
a variety of therapeutic agents, including many AEDs. The permeability of the BBB becomes 
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particularly relevant in drug resistant patients. Also effective concentrations of the AEDs are 
not attained in the brain, because of aberrant functioning of multidrug transporters and 
changes in drug efflux transporters include the overexpression of P-gp (MDR1), MRP1 and 
MRP2 (Oby & Janigro, 2006). The ABC transporter P-gp or MDR1 recognizes a wide range 
of substrates, including a number of AEDs, and is thought to play a major role in drug 
extrusion. MDR1 overexpression has been demonstrated in a variety of cells in both the BBB 
and the parenchyma in patients with intractable epilepsy. Many researchers have shown 
that, there is an overexpression of P-gp in ECs, astrocytes and neurons in a variety of animal 
models of epilepsy. Seizures have been shown to induce overexpression of other 
transporters as well. In many cases the overexpression of efflux drug transporters 
contributes to reduced efficacy of AEDs (Bartmann et al., 2010; Oby & Janigro, 2006; Seegers 
et al., 2002). 
4. Detection of Blood- Brain Barrier dysfunction in epilepsy 
As addressed above, epileptic activity influences the BBB and can result in disturbances of 
its integrity and functionality. From the visible and fluorescence to electron microscope, 
microscopy constitutes as a widely used tool to study the permeability properties of cerebral 
vessels in epilepsy. Conventional visible microscopy is used in detecting focal changes in 
BBB permeability such as in the detection of exogenous tracers or plasma proteins 
immunoreactivity around blood vessels in brain sections. BBB related proteins can therefore, 
be detected by immunocytochemical analysis using a flourescent microscope. 
Transcellular permeability to exogenous tracers can yield valuable information regarding 
barrier integrity. Tracers such as horseradish peroxidase (HRP) and Evans blue were used 
extensively in epilepsy studies (Nag, 2003b). Horseradish peroxidase (HRP) is a plant 
enzyme having a molecular weight of 40,000 daltons and a diameter of 5 nm. When HRP is 
reacted with the oxidizable substrate 3 -3′ diaminobenzidine, an insoluble brown reaction 
product is produced that is easily visualized by light microscopy, and after exposure to 
osmium ions, and is easily detected by electron microscopy. Multifocal areas of HRP 
extravasation from cerebral vessel has been observed in rat brains after epileptic seizures 
(Nag, 2003c). 
Evans blue, a dye with high affinity to serum albumin that is not expected to permeate 
through the BBB, has been used as an indicator of BBB breakdown in epilepsy. Following 
EB injection in an animal, the staining of the brain is evaluated macroscopically against an 
arbitrary staining scale, providing a qualitative evaluation of the BBB permeability 
(Figures 5 and 6). Although this approach has several pitfalls as evaluation is inherently 
subjective, it is still used nowadays, at least as a first approach to assess BBB permeability 
in vivo. Such assessment can be improved by semiquantitative analysis of brain slices by 
fluorescence microscopy or by quantitative determination of the dye in brain 
homogenates (Ahishali et al., 2010; Cardosa et al., 2010; Uzüm et al., 2006; Ilbay et al., 
2003; You et al 2011). Most tracers are labeled by a fluorescent dye or radioactive label 
that helps the quantification of the molecule (Marchi & Teng, 2010). To determine the 
limiting size for permeability, different molecular weight tracers can be used, such as 
fluorescent conjugated dextran (20-,10- and 4-kDa FITC-dextran), propidiumiodide (668 
Da), and sodium fluorescein (376 Da). (Cardosa et al., 2010). The main features of the BBB 
are the presence of tight intercellular junctions, which strictly limit the diffusion of blood-
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borne solutes and cells into the brain. Several studies have been performed regarding 
these junctions, based on commonly used methodologies such as Western blot and PCR, 
as well as several types of microscopy, as addressed above. Using such approaches, 
increased BBB permeability associated with a loss of TJ integrity was also demonstrated in 
models of epilepsy (Ahishali et al., 2010; Rigau et al., 2007). 
Membrane transporters and vesicular mechanisms protect the healthy brain, shielding it 
from toxic substances and allowing the entrance of others that are necessary. Some of the 
most recent studies regarding this barrier include the regulation of major efflux transporters 
in epileptic brains (Bartmann et al., 2010). Immunohistochemical methods are used in 
evaluating P-gp expression induced by seizure in post mortem. Positron emission 
tomography and Single-photon emission computed tomography (SPECT) studies are 
currently describing to asses changes in P-gp expression and functionality in vivo 
(Bartmann et al., 2010; Seegers et al., 2002). The impermeable properties of the BBB 
constitute an obstacle to AEDs delivery to the CNS, essential to treat brain epilepsy. 
Therefore, transport of therapeutic agents across the BBB is an area of intensive research. 
In addition, qualitative evaluation of BBB disruption in humans is available using 
imaging modalities (magnetic resonance imaging, computerized tomography, and SPECT) 
following the peripheral administration of non-permeable contrast agents. Although MRI 
imaging, due to its’ high spatial resolution, is considered the best available method for 
studying anatomical lesions, it is regarded as relatively insensitive for detecting small 
changes in contrast agent accumulation as compared with SPECT. A quantitative 
evaluation of BBB permeability functioning in patients may be obtained using analysis of 
the cerebro-spinal fluid for serum proteins or brain constitutes (e.g. S100ǃ) in the 
peripheral blood. Opening of the BBB provides molecules normally present in blood with 
open passage into the CNS. Proteins normally present in the blood freely diffuse into the 
CNS, and in turn, molecules and protein normally present in high concentrations in the 
CNS freely diffuse into the blood. Such markers of BBB opening can be detected in the 
blood in order to evaluate the permeability characteristics of the BBB. However, these 
methods do not offer spatial information, are invasive, may give false positive results in 
the presence of intracerebral hemorrhage and S100 levels may depend on the extent of 
injury or activation of brain astrocytes (Friedman et al., 2009; Marchi et al., 2010; Marchi et 
al., 2011a).  
   
Fig. 5. Gross evaluation of BBB opening in rat brains. Evan’s blue staining is noticable by 
visual inspection in cerebellum (left), temporal cortex and olfactory bulbs (right).  
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On the other hand, there are studies suggest that a correlation between disrupted BBB and 
abnormal neural activity. Quantitative EEG analysis may offer spatial information of cortical 
dysfunction due to BBB disruption. Spectral EEG analysis reveals slow (delta band) activity in 
regions showing BBB disruption. The usage of quantitative EEG analysis and the detection of 
abnormal BBB permeability may give information not only about the identification of the 
epilectic region, but also for targeting population at risk to develop epilepsy (Friedman et al., 
2009; Mairinger et al., 2011; Marchi et al., 2010; Tomkins et al., 2007) 
     
                                                                   A                                    B 
Fig. 6. Photographs of rat brains are depicted. Evan’s blue staining is seen in the whole brain 
and corresponding slices (B) whereas no stain is present in the other brain slices (A).  
5. Spectral nalysis of EEG signals   
Spectral analysis methods are used for determining the spectral content (distribution of 
power over frequency) of a time series from a finite set of measurements (Kay & Marple, 
1981; Kay, 1988; Proakis & Manolakis, 1996; Stoica & Moses, 1997; Akay, 1998; Akay et al., 
1990). The power spectrum is showing abnormal neural activity caused by BBB disruption 
in the frequency bands.   
The power spectral density (PSD) of the signal is estimated by applying spectral analysis 
methods. The PSD estimates represent the changes in frequency with respect to time. The 
classical methods (nonparametric or fast Fourier transform-based methods), model-based 
methods (autoregressive, moving average, and autoregressive moving average methods), 
time-frequency methods (short-time Fourier transform, wavelet transform), eigenvector 
methods (Pisarenko, multiple signal classification, Minimum-Norm) can be used to obtain 
PSD estimates of the signals (Kay & Marple, 1981; Kay, 1988; Proakis & Manolakis, 1996; 
Stoica & Moses, 1997; Akay, 1998; Akay et al., 1990; Übeyli, 2009a; Übeyli, 2009b; Übeyli, 
2010). The obtained PSD estimates provide the features which are well defining the signals. 
Therefore, spectral analyses of the signals are important in representing, interpreting and 
discriminating the signals (normal and abnormal signals).  
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The frequency resolutions of the fast Fourier transform based (FFT-based) methods are 
limited by the data record duration, independent of the characteristics of the data. The 
spectral leakage occurs due to windowing that are seen in finite-length data records. The 
effect of windowing processing with the FFT-based methods is obtaining smear or smooth 
estimated spectrum (Kay & Marple, 1981; Kay, 1988; Proakis & Manolakis, 1996; Stoica & 
Moses, 1997). The modelling approach for the model-based methods eliminates the need for 
window functions. The statistical stability and spectral resolution properties of the model-
based methods are better and the resolution is less dependent on the length of the record. 
The disadvantages of the model-based methods compared to the FFT-based methods are: 
the FFT-based methods are more widely available and are more widely used approach in 
spectrum analysis; the model-based spectra are slower to compute; the model-based 
methods are not reversible; the model-based methods are slightly more complicated to code; 
the model-based methods are more sensitive to round-off errors, and the orders of the 
model-based methods depend on the characteristics of the signal and the methods for model 
order determination are not sufficient (Kay & Marple, 1981; Kay, 1988; Proakis & Manolakis, 
1996; Stoica & Moses, 1997). The results of the studies existing in the literature are indicating 
high performance of the model-based methods for the time-varying biomedical signals such 
as EEG signals (Übeyli, 2010). 
The time-frequency analysis methods show better performance in spectral analysis of 
nonstationary signals by comparing with the classical and model-based methods. Time and 
frequency resolutions of the short-time Fourier transform (STFT) are fixed over the entire 
time-frequency plane. The STFT assumes that the data are quasistationary for the duration 
of each analyzed segment. The computation of the FFT of a short segment of the signals is 
forming a spectral estimate distortion and leakage of signal energy into spurious side lobes 
due to the sharp truncation of the signal. In order to reduce this distortion, a window 
function is used which reduces the amplitude of the analyzed signal toward the beginning 
and end of the data segment. Using short data windows lead to the distortion and poor 
spectral resolution and using longer data windows lead to the spectral broadening that 
arises from nonstationary characteristics of the signal. In order to solve this problem,  a 
scalable window, which is more flexible approach, can be used (Akay, 1998). The WT solves 
the problem of fixed resolution by using base functions that can be scaled. The wavelets are 
better suited to analyzing nonstationary signals, since they are well localized in time and 
frequency. The property of time and frequency localization is one of the most important 
features of the WT. The WT has a varying window size, being broad at low frequencies and 
narrow at high frequencies, and therefore leading to an optimal time-frequency resolution in 
all frequency ranges. The windows are adapted to the transients of each scale and then the 
wavelets do not require stationarity. The EEG signals are time-varying and random and 
therefore, the WT has become a powerful alternative to the STFT in analysis of the time-
varying biomedical signals (Akay, 1998; Übeyli 2009a).   
The estimation of frequencies and powers of signals from noise-corrupted measurements 
can be performed by the eigenvector methods. Eigen-decomposition of the correlation 
matrix of the noise–corrupted signal is the basic process of the eigenvector methods. The 
resolution of the PSD estimates obtained by these methods is high for the signals having low 
signal-to-noise ratio (SNR). These methods have a good performance for obtaining PSD 
estimates of the signals that can be assumed to be composed of several specific sinusoids 
buried in noise (Akay et al., 1990; Übeyli, 2009b). Therefore, the eigenvector methods have 
good performance in spectral analysis of the EEG signals.  
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6. Conclusion  
BBB is present at the interface between the blood and the CNS. It controls the exchanges 
between the blood and brain compartments, by actively transporting nutrients to the brain, 
and protecting CNS from many toxic compounds and pathogens. Its extremely low 
permeability is due to the endothelial tight junctions and the activity of multiple efflux 
transport systems. BBB dysfunction or BBB opening has long been known in seizure 
disorders and epilepsy. Data from experimental and clinical studies indicates that epileptic 
seizures produce significant alterations in BBB permeability. These BBB alterations are 
reversible and confined to anatomically limited brain areas. Epileptic seizure induced 
disturbances in cerebrovascular permeability involve an interaction between global systemic 
factors and more localised molecular phenomena occuring in the microenvironment of 
recruited neurones. However, cerebrovascular dysfunction has been recently proposed to 
have an etiological role in epilepsy. It is suggested that astrocytic activation, inflammation 
and neuronal damage contribute to epileptogenesis in the BBB- disrupted brain. There are 
several applications used to understand BBB dysfunction in the epileptic brains. The 
exogenous tracers have been used to detect BBB permeability. The endogeneous protein 
extravasations caused by BBB disruption have been detected by immunohistochemistry. 
Magnetic resonance imaging, positron emission tomography, computerized tomography, 
and SPECT studies are currently described to assess changes in BBB permeability. In 
addition, evaluation of BBB disruption is available using EEG analysis. Spectral analyses of 
the signals are important in representing, interpreting and discriminating the signals 
(normal and abnormal signals). Finally, spectral analysis methods can be used for obtaining 
the power spectrum those showing abnormal neural activity caused by BBB disruption in 
the frequency bands.  
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